Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.55+0.00 (0.00%)
Close on Nov 17, 2026Market cap $254.69MP/E –Yield –
Turn Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Turn Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was -$5.28M. For fiscal 2025 it was -$2.56M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.56M | – |
| FY2024 | Dec 31, 2024 | -$1.36M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.55M | – |
| Q2 FY2026 | Jun 30, 2026 | -$923.36K | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.63M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$588.61K | – |
| Q2 FY2025 | Jun 30, 2025 | -$499.97K | – |
| Q1 FY2025 | Mar 31, 2025 | -$298.06K | – |
| Q4 FY2024 | Dec 31, 2024 | -$430.55K | – |
See a number that looks wrong?